HCPLive

Genetic Variations Confer Risk for Multiple Psychiatric Disorders

THURSDAY, Feb. 28 (HealthDay News) -- Specific single nucleotide polymorphisms (SNPs) seem to confer risk of a diverse set of psychiatric disorders, according to a study published online Feb. 28 in The Lancet.

Jordan W. Smoller, MD, from Massachusetts General Hospital, in Boston, and colleagues from the Cross-Disorder Group of the Psychiatric Genomics Consortium examined genome-wide SNP data for autism spectrum disorder, attention-deficit/hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia in 33,332 cases and 27,888 controls of European ancestry. The allelic effects of each disorder were characterized.

In the primary analysis the researchers found that SNPs at four loci (regions on chromosomes 3p21 and 10q24 and within two L-type voltage-gated calcium channel subunits) exceeded the cut-off for genome-wide significance. The effects of these loci were supported for several disorders. Variable diagnostic specificity was seen for loci previously associated with bipolar disorder or schizophrenia. Based on polygenic risk score analysis there were cross-disorder associations, particularly between disorders with adult onset. For all five disorders, pathway analysis supported a role for genes in calcium channel signaling. Enrichment of brain-tissue expression quantitative trait loci was seen in SNPs with evidence of cross-disorder association.

"Our findings show that specific SNPs are associated with a range of psychiatric disorders of childhood onset or adult onset," the authors write. "These results provide evidence relevant to the goal of moving beyond descriptive syndromes in psychiatry, and towards a nosology informed by disease cause."

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Copyright © 2013 HealthDay. All rights reserved.

Most Popular

Recommended Reading

A new study finds that 4.3 million Americans with full-time jobs had an anxiety disorder in the past year. That number represents 3.7 percent of full-time workers aged 18 and older, according to the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA).

The number of US children and teens being treated for mental health issues has risen by about 50 percent in the past 20 years -- with most of those children having relatively mild symptoms, according to research published in the May 21 issue of the New England Journal of Medicine.

The results of the largest study of its kind to date indicate that new antipsychotic medications—including quetiapine, olanzapine, and risperidone—do not appear to put women at additional risk of developing gestational diabetes, hypertensive disorders, or major blood clots that obstruct circulation, all conditions that often develop during pregnancy or with the use of older antipsychotic medications.
Fatal drownings happen even in strong, healthy swimmers in lifeguarded pools. A New York City health department investigation points to an under-reported cause: deliberate breath-holding as part of informal contests or self-imposed training regimens.
$vAR$